Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus.
Where this comes from
- Record sourced from PubMed, PMID 37263652.
- Also identified by DOI 10.3899/jrheum.2022-1335.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Women with systemic lupus erythematosus (SLE), especially when exposed to immunosuppressive drugs, are at higher risk of human papillomavirus (HPV)-related cervical cancer.<sup>1</sup> A recent study has shown that cervical cancer screening (CCS) coverage is worryingly low in this population.<sup>2</sup>.